Our portfolio

CEPI is working to end pandemics by supporting the research and development of a diverse portfolio of vaccine candidates.
CEPI funds the development of vaccine candidates against our known priority pathogens and vaccine platforms to enable rapid development of vaccines against Disease X.
Our interactive portfolio provides information on each of the vaccine candidates that CEPI has invested in as well as our Centralised Lab Network, Preclinical Models and Vaccine Manufacturing Network partners.
Filter information by developer, disease, phase of development or vaccine type. You can also download a summary of our active portfolio.
Additional CEPI-funded partnerships will be added in the coming months to provide a full overview of CEPI’s investments.
©2026 CEPI. All rights reserved